| Date Posted |
Subject |
| Dec. 27, 2003 |
Advantages and challenges of a centralized off-site transfusion service for hospitals ADDENDA Dec. 27; Jan. 3 & 8, 2004 |
| Dec. 24, 2003 |
Methods for Warming Blood Products |
| Dec. 22, 2003 |
Screening for quality of platelet concentrates by testing for EDTA-induced platelet shape changes |
| Dec. 18, 2003 |
Experience Using the Blood-Loc (TM) and Other Barrier Systems to Prevent Transfusion of Blood to the Wrong Patient ADDENDA Dec. 31 |
| Dec. 16, 2003 |
Should Red Blood Cells and Platelet Concentrates Be Labeled for Content? ADDENDA Dec. 17, 19, 23 & 31, 2003; REACTIVATED Dec. 23, 2004 |
| Dec. 14, 2003 |
An effort to minimize unexpected neonatal readmissions through the use of an "HDN Directive" ADDENDA Dec. 17 |
| Dec. 12, 2003 |
What size of screen filter should be used for infusing peripheral blood stem cells? ADDENDA Dec. 17 |
| Dec. 9, 2003 |
Policy for management of reactions developing after a blood donor leaves the collection site ADDENDA Dec. 12 |
| Dec. 9, 2003 |
If electronic images of testing instrumentation data are validated to show that the data is identical to those of hard-copy printouts from the instrument, would a facility be required to keep the printouts from the instrument? |
| Dec. 8, 2003 |
Strategies to improve utilization of blood products by emergency room physicians |
| Dec. 2, 2003 |
Protocols
for the detection and treatment of TRALI ADDENDA Dec.
3, 4, 10, 12 & 16; Jan. 2, 2004; Aug. 12, 2005; Mar. 19 & 30, 2008 |
| Nov. 28, 2003 |
Eligibility
for pre-operative autologous donation by brain
tumor patients who had a recent seizure ADDENDA Dec.
1, 2 & 3; Aug. 30, 2007 |
| Nov. 20, 2003 |
Increased breakage rate of leukoreduced Red Blood Cells transported in a pneumatic tube system ADDENDA Nov. 25 |
| Nov. 18, 2003 |
Administering antipyretics and antihistamines to prevent febrile reactions to blood transfusion ADDENDA Nov. 19, 20 & 28; Apr 12 & 13, 2005 |
| Nov. 17, 2003 |
Questions about a 'Walking Blood Donor Program' in remote geographic areas ADDENDA Nov. 17, 18 & 26 |
| Nov. 14, 2003 |
Platelet recovery 'in lab' and after transfusion of volume-reduced platelets ADDENDA Nov. 17 |
| Nov. 12, 2003 |
References on patient outcomes following transfusion of ABO incompatible platelets ADDENDA Nov. 13 |
| Nov. 7, 2003 |
Why do transfusion services in the US not consider Kell antigen when crossmatching red cells intended for women of childbearing age? ADDENDA Nov. 10 |
| Oct 29, 2003 |
Practices regarding RhIG administration in response to 22nd edition of AABB Standards ADDENDA Nov. 3 |
| Oct 28, 2003 |
Preoperative blood support for a patient with post-transfusion thrombocytopenic purpura |
| Oct 28, 2003 |
Is irradiation necessary for cellular blood products intended for patients receiving Fludarabine and/or similar drugs for low-grade non-Hodgkin's lymphoma? ADDENDA Nov. 10, 14, 24 & 26; Dec. 12 REACTIVATED Dec. 13 |
| Oct 25, 2003 |
Guidelines for blood utilization/justification for transfusion ADDENDA Oct. 28 & 30 |
| Oct 24, 2003 |
The effect of handwritten vs computer-generated labels on the rate of misidentified samples received for compatibility testing ADDENDA Oct. 25, 26, 27 & 28; Dec. 19 |
| Oct 15, 2003 |
Protocols for 'identifying' unidentified trauma patients who need emergency transfusion ADDENDA Oct. 16 & 29; Nov. 7; Mar 8 & 9, Apr 13, 2005 |
| Oct 14, 2003 |
Extraordinary
effort to accommodate requests for autologous
and directed donations ADDENDA Oct.
15 & 16; Dec. 29, 2007 |
| Oct 13, 2003 |
A complex ethical issue in a husband-to-wife directed donation ADDENDA Oct. 14 & 15 |
| Oct 10, 2003 |
FDA Proposal to expand the definitions of what is a reportable "suspected adverse reaction" ADDENDA Oct. 13, 14 & 16 |
| Oct 9, 2003 |
Is transfusion of platelets contraindicated during dialysis? ADDENDA Oct. 10 |
| Oct 9, 2003 |
Removing air from component bags prepared from whole blood leukocyte-reduced by filtration ADDENDA Oct. 11, 14 & 16 |
| Oct 9, 2003 |
PC-based 'Expert System' Applications for Troubleshooting a Blood Bank Computer System |
| Oct 3, 2003 |
Procedures to minimize errors in selection of blood products for transfusion to ABO/Rh mismatched bone marrow transplant recipients ADDENDA Oct. 6 & 10, Dec. 15; June 13, 15 & 16, 2004; July 7, 2006 |
| Oct 3, 2003 |
Proposed FDA requirement to lower the current storage temperature for FFP (-18 C or less) and to list all donor tests on the product label ADDENDA Oct. 6, 7, 8, 14 & 22 |
| Oct 1, 2003 |
Maintenance, storage and retrieval of transfusion service records |
| Sept 25, 2003 |
How do large hospitals transport blood products to patient care areas for transfusion? ADDENDA Sept. 26 & Oct. 2 |
| Sept 25, 2003 |
Will a policy of standing orders for irradiation of blood products affect third-party reimbursement? ADDENDA Sept. 25 |
| Sept 20, 2003 |
What irradiation dose is sufficient for inactivating GVHD-causing leukocytes in all blood donors? ADDENDA Sept. 22, 25 & 26 |
| Sept 20, 2003 |
Should the AABB standard allowing omission of red cell antibody screening for infants under 4 months of postnatal age be extended for infants born prematurely? ADDENDA Sept. 23 & Oct. 2 |
| Sept 19, 2003 |
Reconstituting blood for exchange transfusion in neonates ADDENDA Sept. 22, 24 & 25; Nov. 7 & 10; Apr. 5 & 15, Dec. 15, 2008 |
| Sept 17, 2003 |
The effect of irradiation on aliquots of blood in syringes ADDENDA Sept. 20 & 22 |
| Sept 14, 2003 |
A case of suspected Kell HDN with apparent discrepancy between red cell antigen typing of fetal red cells by standard serologic techniques and amniocyte antigen typing by PCR ADDENDA Sept. 16, 18 & 20 |
| Sept 9, 2003 |
Complying with AABB HPC Standard 9.1.7.2. (Cleanliness of Human Progenitor Cell Facilities) |
| Sept 7, 2003 |
Is a person with a history of filariasis eligible to make a blood donation? |
| Sept 4, 2003 |
Using pH and glucose dipsticks to screen for contaminated platelets ADDENDA Sept. 6 & 7; Jan. 10, 14 & 26, 2004 |
| Sept 2, 2003 |
Management of transfusing Rh-positive RBCs to Rh-negative recipients in times of severe shortage ADDENDA Sept. 8 |
| Aug 30, 2003 |
A case report of an allergic type reaction to the injection of RHIG ADDENDA Sept. 1, 2 & 4 |
| Aug 27, 2003 |
What is the frequency of hemolytic reactions associated with transfusion of plateletpheresis units containing ABO incompatible plasma? ADDENDA Aug. 28, Sept. 3, 5 & 9; Sept. 2, 8, 20 & 29; Oct. 3, 2005 |
| Aug 25, 2003 |
Methods for ensuring adherence of labels applied to frozen blood products ADDENDA Aug. 26 |
| Aug 24, 2003 |
Survey on
Informed Consent for Transfusion ADDENDA Aug.
25, 26, 28, 30 & Sept. 1; Feb. 9 & Mar. 15 & 23, 2007;
Jan. 29 & Oct. 24, 2008 |
| Aug 21, 2003 |
Crossmatch testing for patients with a weak (cold) antibody present only in reverse grouping at 4 degrees C ADDENDA Aug. 22 & 24 |
| Aug 19, 2003 |
When is it OK to discard umbilical cord blood stem cells? |
| Aug 16, 2003 |
How Well Do You Know Your Emergency Power System? ADDENDA Aug. 28, Oct. 7 & 8 |
| Aug 15, 2003 |
An unusual case report of massive feto-maternal hemorrhage in an Rh negative woman ADDENDA Aug. 18 |
| Aug 15, 2003 |
When should a transfusion reaction investigation be initiated by the transfusion service technologist? ADDENDA Aug. 18 |
| Aug 12, 2003 |
Should an AHG crossmatch be performed on a patient with a positive Gel-AHG antibody screen, but a negative or equivocal Gel-AHG panel? ADDENDA Aug. 13 & 14 |
| Aug 5, 2003 |
Questionnaires to identify donors or staff who might have latex allergy ADDENDA Aug. 6 & 7 |
| Aug 4, 2003 |
Managing a healthy blood donor who has a positive direct antiglobulin test (DAT) ADDENDA Aug. 5 & 14 |
| Aug 1, 2003 |
Hyperbilirubinemia after transfusing 'older' red cell units to very small neonates ADDENDA Aug. 3, 4 & 18 |
| Aug 1, 2003 |
Managing discrepant results from repeat HemoCue tests when screening donors for anemia ADDENDA Aug. 4, 5, 6, 8, 11 & 12 |
| July 31, 2003 |
Managing an autologous donor whose blood is reactive in West Nile Virus nucleic acid testing (NAT) ADDENDA Apr 27, May 3, 4 & 7, 2005 |
| July 29, 2003 |
Clinical significance of anti-Sd(a) - conflicting results with tube and gel antiglobulin tests ADDENDA July 30 & 31 |
| July 28, 2003 |
Asymptomatic chlamydia urinary tract infection (UTI) and donor eligibility ADDENDA July 30 |
| July 26, 2003 |
How good is HIV NAT for detection of HIV-1 Group O infection? ADDENDA Aug. 23 |
| July 26, 2003 |
Why must there be followup testing for a 'false positive' WNV donor? ADDENDA Aug. 23 & 28 |
| July 23, 2003 |
Should the hospital pharmacy participate in the dispensing of Rh Immune Globulin (RhIg)? |
| July 22, 2003 |
Is the presence of ant-Jk(a) in a patient of concern when considering a living related kidney transplant from a donor who is Jk(a) positive? ADDENDA July 23 |
| July 21, 2003 |
Reducing the size of platelet concentrate pools as a means of coping with product shortages and rising costs ADDENDA July 22, 23, 24 & 25 |
| July 21, 2003 |
Supporting neonates with plateletpheresis units ADDENDA July 22 & 24 |
| July 19, 2003 |
Management of samples used for pre-transfusion testing ADDENDA July 21 & 28 |
| July 12, 2003 |
Palpating a blood donor's vein after preparing the venipuncture site ADDENDA July 14 & 17 |
| July 12, 2003 |
Maintaining an inventory of non-leukoreduced blood for "direct cost" savings from one's blood supplier ADDENDA July 13, 14, 22, 24, 25 & 26 |
| July 9, 2003 |
How long may a primed ECLS/ECMO circuit run without a patient connected? ADDENDA July 16, 2003; Mar. 28, 2007 |
| July 6, 2003 |
Using only group O red cells for neonates ADDENDA July 7, 8, 10, 11 & 14 |
| July 1, 2003 |
Recommended (or Maximum) Surgical Blood Order Schedules (RSBOS or MSBOS) for cardiac surgery ADDENDA July 2 & 3 |
| July 1, 2003 |
When infusion of a blood component is begun just before its expiration date but not completed at the time of expiration, must the infusion be terminated? ADDENDA July 2, 3, 7 & 9; Oct. 17 & 21, 2005 |
| June 30, 2003 |
Management of deferral during a computerized donor health history ADDENDA July 1 & 7 |
| June 30, 2003 |
What forms of proof of identity are required of prospective blood donors? ADDENDA July 1, 3 & 5; Nov. 12, 2006 |
| June 26, 2003 |
In patients receiving daily red cell transfusions should a 3-day-old pre-transfusion specimen still be considered acceptable? ADDENDA June 27 |
| June 25, 2003 |
Does a hospital transfusion service need to register with the FDA to perform therapeutic phlebotomy? ADDENDA June 26 |
| June 24, 2003 |
What is an appropriate C/T ratio for pediatric surgery? ADDENDA June 25 & 27; July 7 |
| June 21, 2003 |
What are the criteria for notifying the physician of a recipient of a recalled blood product? ADDENDA June 23; Jan. 23 & 29, 2004 |
| June 18, 2003 |
Is iron prophylaxis needed for non-anemic cancer patients undergoing preoperative autologous donation? |
| June 17, 2003 |
Transfusions to patients with antibodies to low incidence antigens |
| June 11, 2003 |
What is the justification for the charting of transfusion forms attached to blood components? ADDENDA June 16 |
| June 9, 2003 |
Does African monkeypox virus pose a threat to the blood supply? ADDENDA June 11 |
| June 8, 2003 |
Donor eligibility of a man who dresses as a woman in anticipation of sex change surgery ADDENDA June 9, 10, 11 & 12; Feb. 27 & Mar. 10, 2004; Apr. 28 & May 22, 2007 |
| June 6, 2003 |
Storage of blood for patients transported on emergency flights ADDENDA June 10, July 28 & July 29, Aug. 1 |
| June 4, 2003 |
Does new evidence exist on the safety of using automatic IV infusion pumps for red cell transfusions? ADDENDA June 7 & 11 |
| June 2, 2003 |
What criteria are used to decide when a change to an SOP requires an updated version number? ADDENDA June 11 |
| June 1, 2003 |
Comments on the Federal Register proposed rules "Safety Reporting Requirements for Human Drug and Biological Products", Docket No. 00N-1484, CDER 199665, posted March 14, 2003 |
| May 29, 2003 |
For preventing post-transfusion CMV, does recent data merit a reassessment of the equivalence of leukoreduction to use of seronegative donors? ADDENDA June 1 & 2 |
| May 29, 2003 |
What is the experience with using washed red cells for the immediate spin test to reduce the nondetection rate for ABO incompatibility? ADDENDA June 3 |
| May 29, 2003 |
Experience with using a blood storage refrigerator in the Operating Room ADDENDA June 1, 4, 5, 6, 10 & 11; Apr 8, 11; May 24 & Aug. 19 & 25, 2005 |
| May 27, 2003 |
Limitation to
new method for quantification of feto-maternal
haemorrhage (FMH) by flow cytometry with anti-fetal
haemoglobin ADDENDA Jan
29, 2005; July 9 & 11, 2007 |
| May 26, 2003 |
Monitoring patients while they receive IVIG ADDENDA May 27 |
| May 22, 2003 |
How often should a patient with known IgA deficiency be retested for development of anti-IgA antibodies? ADDENDA May 23 |
| May 18, 2003 |
What is the required documentation in a patient's medical record for transfusion of blood and blood products when an electronic medical record is employed? ADDENDA May 19 |
| May 15, 2003 |
Should laboratory assistants and other non-medical technologists be permitted to dispense blood products for transfusion? ADDENDA May 16, 19, 20 & 22 |
| May 13, 2003 |
Should consent for transfusion be required for plasma derivatives? ADDENDA May 14; April 9, 2008 |
| May 8, 2003 |
A network dialogue on the question of using a second blood sample to verify a patients ABO/Rh type ADDENDA May 9, 14, 20, 22 & June 1 |
| May 3, 2003 |
What do colleagues do in their practice regarding testing for fetomaternal bleeds and/or the use of micro versus full doses of RHIG? ADDENDA May 8; Oct. 7, 2005 |
| May 3, 2003 |
What is a reasonable parallel testing scheme for verifying equivalence between a manual tube technique and a gel automated technique? |
| Apr. 29, 2003 |
How well do clinicians document the reasons for their order to transfuse a patient? ADDENDA April 30, May 1, 2, 5 & 6; Apr. 24, May 13 & 25, June 1, 2007 |
| Apr. 27, 2003 |
Thoughts on why anti-G does NOT appear to protect against the development of anti-D |
| Apr. 23, 2003 |
American Red Cross announces plan to screen donated blood for West Nile Virus (WNV) |
| Apr. 21, 2003 |
Can Rh-positive FFP induce anti-D alloimmunization in an Rh-negative recipient? ADDENDA April 22, 23, 24 & 25 |
| Apr. 16, 2003 |
During a blood shortage what inventory levels and other criteria are used by transfusion services to decide when to postpone elective surgery? ADDENDA April 17 & 19 |
| Apr. 15, 2003 |
Is it necessary to use commercial WBC controls when using a Nageotte Counting Chamber for QC of leukoreduced blood products? ADDENDA April 16 |
| Apr. 13, 2003 |
Manual methods for washing small aliquots of red cells from a single unit dedicated for transfusion to hyperkalemic neonates ADDENDA April 15 |
| Apr. 13, 2003 |
Should the California Donor Deferral Register be eliminated? ADDENDA April 15, 16, 17, 22, & 23, July 5, Sept. 23, 24 & 25 |
| Apr. 10, 2003 |
Safety of drawing selected autologous donors into 500 ml collection bags |
| Apr. 10, 2003 |
Policies regarding irradiation of blood donated by blood relatives ADDENDA Apr. 10 |
| Apr. 7, 2003 |
Who should be responsible for ensuring that there is a written order for transfusion before blood is issued and infused? ADDENDA April 11, 14 & 28 |
| Apr. 7, 2003 |
What is the distribution of hematocrits among donors who qualify to donate a full 500 mL of whole blood? |
| Apr. 3, 2003 |
How do blood collection centers manage subsequent donations by donors who choose the confidential unit exclusion ('CUE') option? ADDENDA April 4, 6, 7, 9 & 14 |
| Apr. 2, 2003 |
What are the QC requirements for isotonic saline used with automatic cell washers? ADDENDA April 5 |
| Apr. 2, 2003 |
Confusion about the para-Bombay phenotype ADDENDA April 6 |
| Apr. 1, 2003 |
Who should validate computer software used in blood banks/transfusion services? ADDENDA April 2, 3, 6, 7, 9, July 25, Aug. 12, 21, Sept. 15 & 17, Oct. 3, 5 & 7 |
| Mar. 31, 2003 |
Should a prospective donor be deferred following exposure to 'SARS'? ADDENDA April 2, 12 & 18 |
| Mar. 30, 2003 |
Is monitoring of transfusion reactions by a hospital committee required by any regulatory or accrediting agencies? ADDENDA April 1, 9 & 15 |
| Mar. 29, 2003 |
Risks of carbon dioxide release from FFP packed with dry ice ADDENDA Dec 22, 2004 |
| Mar. 21, 2003 |
What guidelines do hospital Transfusion Services use to validate blood products transported in a Pneumatic Tube System? ADDENDA May 5, 2005 |
| Mar. 16, 2003 |
Should persons with thrombophilia be accepted as blood donors? ADDENDA Mar. 21, 29 & 31 |
| Mar. 10, 2003 |
How are blood banks or transfusion services planning to address the new AABB requirement to have methods to limit and detect bacterial contamination in all platelet components? ADDENDA Mar. 10 & 11 |
| Mar. 6, 2003 |
Are laboratories following the requirement to use complement-coated RBCs for validating negative direct antiglobulin tests (DATs) performed with anti-C3b, -C3d reagents? ADDENDA Mar. 12 & 13 |
| Mar. 5, 2003 |
High-dose plasma infusion versus plasma exchange as early treatment of thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome ADDENDA Mar. 7 & 10 |
| Feb. 24, 2003 |
When acute normovolemic hemodilution is used for surgery lasting over 8 hours, should the collected blood be kept at room temperature and reinfused within 8 hours (to comply with AABB Standards) or should it be refrigerated until needed? ADDENDA Mar. 3 & 11 |
| Feb. 19, 2003 |
What procedures are institutions following to assure that organs intended for transplantation are properly matched for ABO, HLA and other antigens? ADDENDA Feb. 20, 24, 26 & 28 |
| Feb. 19, 2003 |
Practical management of directed donations for patients with cancer ADDENDA Feb. 21 & 24, Mar. 3 |
| Feb. 16, 2003 |
Is simultaneous crossmatching of multiple patients by the same technologist permissible under current JCAHO requirements? ADDENDA Feb. 17; Jan. 16, 2007 |
| Feb. 15, 2003 |
Planning for a natural or man-made disaster at hospitals and blood centers ADDENDA Feb. 16 & 24; Apr. 21 & 27, 2007 |
| Feb. 14, 2003 |
What percentage of red cells are transfused to oncology patients? ADDENDA Feb. 17 & 20 |
| Feb. 11, 2003 |
In regard to the recent problem of 'white particulates' in blood, must the recommended inspection be performed at the time the blood is issued for transfusion, or can it be done earlier? ADDENDA Feb. 12, 14 & 27 |
| Feb. 11, 2003 |
Should a victim of date-rape be deferred as a blood donor? ADDENDA Feb. 12 & 18 |
| Feb. 9, 2003 |
Is it permissible to release for transfusion a blood component that shows icteric plasma, drawn from a donor who is otherwise acceptable and whose hepatitis tests are negative? ADDENDA Feb. 10, 11 & 13 |
| Feb. 8, 2003 |
Use of plastic tubes for collection of patient samples as well as for testing (ABO/Rh determination, unexpected antibody detection and identification, and crossmatching) REACTIVATED Sept. 29; ADDENDA Sept. 30, Oct. 1 |
| Feb. 8, 2003 |
When is a very slow pulse rate in a fit elderly blood donor a cause for concern? ADDENDA Feb. 10, June 3, 4, 5 & 7 |
| Feb. 3, 2003 |
Reconciling conflicting results for Rh typing using different test reagents ADDENDA Feb. 4 & 5, 2003; Mar. 25, 2007; June 11, 2008; Jan. 18, 2009 |
| Feb. 2, 2003 |
How sensitive is visual examination in detecting gross abnormalities in the appearance of blood products issued to patients for transfusion? |
| Jan. 31, 2003 |
Is there a regional
or national computerized database of patients
with multiple red cell antibodies or other complex transfusion
histories? ADDENDA Feb.
5, 2003; Apr. 19, 20, 26 & May 5, 2004; Nov. 16 & 20, 2005;
June 7, 8, 9 & 12, 2006; Mar. 18, 2008 |
| Jan. 30, 2003 |
Do institutions that use the Gel method for ABO grouping encounter ABO grouping discrepancies due to failure of the test system to detect expected ABO antibodies? ADDENDA Jan. 31, Feb. 5 & 6 |
| Jan. 29, 2003 |
Is there an impending shortage of anti-HTLV-I/II test kits? ADDENDA Feb. 5 |
| Jan. 26, 2003 |
Case study of a patient with both red cell autoantibodies and alloantibodies ADDENDA Jan. 28 & 29 |
| Jan. 23, 2003 |
How has the e-Network Forum been helpful to colleagues in transfusion medicine? ADDENDA Jan. 27, 28 & 30; Feb. 2, 4, 5, 6 & 10; Mar. 31; April 7, 10, 23, 28 & May 14; July 31; Aug. 6 & 11, 2003 ..... |
| Jan. 23, 2003 |
Is it ever acceptable to intentionally transfuse ABO-incompatible RBCs? ADDENDA Jan. 24, 27, 28 & 29; Mar. 31 |
| Jan. 22, 2003 |
Where do hospitals store 'oxygen therapeutics' solutions (blood substitutes)? |
| Jan. 18, 2003 |
Is it possible to administer IVIG (or IMIG) to an IgA-deficient patient with anti-IgA who has had a previous anaphylactic reaction to IVIG? ADDENDA Jan. 21, 22 & 29 |
| Jan. 17, 2003 |
Distinguishing
anti-G from anti-C+D in prenatal serologic studies ADDENDA Jan.
20 & 21; Mar. 16, 2009 |
| Jan. 14, 2003 |
What is the acceptable upper limit of storage temperature for FFP, and its scientific basis? ADDENDA Jan. 15 & 30; Feb. 3 & 12 |
| Jan. 13, 2003 |
Failure to complete Type and Screen testing until surgery has started ADDENDA Jan. 14 & 27 |
| Jan. 9, 2003 |
Is anyone aware of donor information materials in braille for blind/sight-impaired persons? ADDENDA Jan. 10, 15 & 16 |
| Jan. 7, 2003 |
In performing titration studies for NON-Rh antibodies in pregnant women, what is the practice regarding selection of reagent red cells that are heterozygous vs homozygous for the antigen in question? ADDENDA Jan. 9; Dec. 21, 2005 |
| Jan. 5, 2003 |
In Jehovah's Witnesses with AML, what are the chances that intensive chemotherapy without blood component support will induce a sustained remission? |
| Jan. 1, 2003 |
In selecting Rh positive reagent red cells for prenatal anti-D studies does the Rh phenotype affect the results of the titration? ADDENDA Jan. 2 & 6 |
| Jan. 1, 2003 |
What is the risk of transmission of Lyme Disease by blood donated years after recovery from an untreated infection? |
Back to Top 
The e-Network Forum is supported in part by the California Blood Bank Society (CBBS) and the American Red Cross Blood Services (ARCBS) and endorses collegial discussion among blood banking and transfusion medicine professionals. However, neither the CBBS nor the ARCBS in any way endorse the specific views and opinions expressed in the forum. The forum is not intended as a substitute for medical or legal advice and the content should not be relied upon for any medical or legal purposes. Readers should make their own determinations as to: (i) what constitutes appropriate medical, technical, and administrative practices, and (ii) how best to comply with laws and regulations relevant to their questions. For the latter, they should consider consulting, as to any medical matters, a qualified physician, and, as to any legal matters, an attorney familiar with related state and federal laws. The user of the forum, by accessing same, assumes all risks arising out of such use and releases CBBS and their respective members, directors, officers and agents from and against any loss, damage, claim or liability arising out of such use of the Forum.
